Early prostate-specific antigen (PSA) response or progression and survival | Download Table
Cancers | Free Full-Text | Variables Associated with False-Positive PSA Results: A Cohort Study with Real-World Data
Measurement of total and free prostate specific antigen (PSA) in human serum samples using an ultra-microanalytical system - ScienceDirect
xmlinkhub
Development of a glycoproteomic strategy to detect more aggressive prostate cancer using lectin-immunoassays for serum fucosylated PSA | Clinical Proteomics | Full Text
Proteolytic Activity of Prostate-Specific Antigen (PSA) towards Protein Substrates and Effect of Peptides Stimulating PSA Activity | PLOS ONE
Treatment strategy for metastatic prostate cancer with extremely high PSA level: reconsidering the value of vintage therapy | Semantic Scholar
Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL. - Abstract - Europe PMC
Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer | PLOS ONE
MP28-17 THE ADDITION OF BIOMARKERS TO PSA AND MPMRI MAY IMPROVE PROSTATE CANCER DETECTION RATE | Journal of Urology
Kaplan-Meier survival curves of (a) PSA-progression-fre | Open-i